BIOTEST AG ST O.N./ DE0005227201 /
| 11/14/2024 8:20:00 AM | Chg. 0.0000 | Volume | Bid8:51:32 AM | Ask8:51:32 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 41.0000EUR | 0.00% | 0 Turnover: 0.0000 |
41.0000Bid Size: 100 | 42.0000Ask Size: 100 | 2.43 bill.EUR | - | 12.81 |
Assets
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 512.7000 | 521.9000 | 522.2000 | 524.7000 | 520.3000 | ||||||
| Intangible Assets | 16.4000 | 13.8000 | 14 | 11.3000 | 9.2000 | ||||||
| Long-Term Investments | 7.4000 | 7.6000 | .2000 | 5.6000 | 5.1000 | ||||||
| Fixed Assets | 547.2000 | 585.6000 | 575 | 582 | 583.6000 | ||||||
| Inventories | 208.3000 | 280.1000 | 290.1000 | 244.6000 | 293.8000 | ||||||
| Accounts Receivable | 118.7000 | 107.7000 | 115.8000 | 107.3000 | 124.5000 | ||||||
| Cash and Cash Equivalents | 61.9000 | 60.8000 | 71.3000 | 104.4000 | 116.6000 | ||||||
| Current Assets | 495.1000 | 522.8000 | 556.3000 | 522.2000 | 619.4000 | ||||||
| Total Assets | 1,042.3000 | 1,108.4000 | 1,131.3000 | 1,104.2000 | 1,203 | ||||||
Liabilities
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 73.4000 | 52.2000 | 42 | 38.8000 | 51.1000 | ||||||
| Long-term debt | 328.7000 | 402.9000 | 462.5000 | 496.4000 | 612.8000 | ||||||
| Liabilities to Banks | 329.4000 | 410.4000 | 470.4000 | 531.2000 | - | ||||||
| Provisions | 29.3000 | 28.9000 | 29.4000 | 25 | 115.2000 | ||||||
| Liabilities | 547.1000 | 631.5000 | 689.7000 | 723.8000 | 831.9000 | ||||||
| Share Capital | 39.6000 | 39.6000 | 39.6000 | 39.6000 | - | ||||||
| Total Equity | 495 | 476.9000 | 441.6000 | 380.4000 | 371.1000 | ||||||
| Minority Interests | .2000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 1,042.3000 | 1,108.4000 | 1,131.3000 | 1,104.2000 | 1,203 | ||||||
Income Statement
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 400.3000 | 419.1000 | 484.2000 | 515.6000 | 516.1000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | 10.6000 | -1.2000 | -1.3000 | -47.1000 | -16.6000 | ||||||
| Interest Income | -11.3000 | -10.5000 | -28.2000 | -16.8000 | -13.2000 | ||||||
| Income Before Taxes | -6 | -1.3000 | -30 | -62.6000 | -30.8000 | ||||||
| Income Taxes | 6.9000 | 3.4000 | 1.4000 | .7000 | -.8000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | 181.7000 | -4.7000 | -31.4000 | -63.4000 | -31.7000 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
2021 IFRS in mill. EUR |
2022 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -50 | -33.6000 | -16.7000 | 33.9000 | -40.5000 | ||||||
| Cash Flow from Investing Activities | 200.8000 | -8 | -14.6000 | -23.4000 | -37 | ||||||
| Cash Flow from Financing | -111.2000 | 40.5000 | 42 | 22.6000 | 89.6000 | ||||||
| Decrease / Increase in Cash | 39.6000 | -1.1000 | 10.7000 | 33.1000 | - | ||||||
| Employees | 1,663 | 1,837 | 1,928 | 1,967 | 2,228 | ||||||
